查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595314

药品合约包装市场：按材料和应用分类 - 2025-2030 年全球预测

Pharmaceutical Contract Packaging Market by Material (Aluminum Foil, Glass, Paper & Paperboard), Application (Ampoules, Blister Packs, Bottles) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年药品合约包装市场规模为320.7亿美元，预计2024年将达348.2亿美元，复合年增长率为8.91%，2030年将达583亿美元。

药品合约包装是指製药公司将包装服务外包给第三方提供者。这个行业至关重要，因为它使製药公司能够专注于其核心竞争力，例如药物开发和行销，同时利用合约包装商的专业知识和能力来确保遵守行业标准和法规。药物配方和包装要求日益复杂、监管力度加大以及对更永续包装解决方案的推动推动了合约包装的需求。合约包装的应用包括泡壳包装、瓶子填充、标籤和二次包装，最终用途范围从契约製造组织 (CMO) 到製造非处方药 (OTC) 和道德药品的製药公司。

主要市场统计
基准年[2023] 320.7亿美元
预测年份 [2024] 348.2亿美元
预测年份 [2030] 583亿美元
复合年增长率（%） 8.91%

根据市场洞察，关键的成长要素包括对需要创新包装解决方案的生技药品和特种药物的需求不断增长、製药行业外包趋势的增加以及序列化和追踪系统等包装，其中包括工程技术的进步。市场相关人员的机会包括扩大服务组合，纳入环保包装解决方案，以及采用数位技术简化包装流程。此外，随着製药业的发展，向新兴市场的地域扩张呈现出良好的前景。然而，挑战包括严格的监管要求、成本压力以及全球经济不确定性导致的需求波动。

创新的希望在于开发智慧包装解决方案，以提高患者用药依从性、提高供应链透明度并促进身分验证。生物分解性和可回收材料的持续研究可以提供竞争优势。由于快速的技术进步和监管变化，市场竞争激烈且充满活力。为了实现永续的业务成长，公司应投资最尖端科技并建立策略伙伴关係和联盟，以增强服务交付。此外，积极主动的合规方法和对客户独特需求的高度关注对于在这个不断发展的市场中应对挑战和抓住机会至关重要。

市场动态：揭示快速发展的药品合约包装市场的关键市场洞察

供需的动态交互作用正在改变药品合约包装市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 製药业对方便、防篡改包装的需求不断增长
    • 全球药品製造及出口增加
    • 严格的药品包装政府标准
  • 市场限制因素
    • 先进和客製化的药品合约包装服务高成本
  • 市场机会
    • 药品包装解决方案的技术进步
    • 对药物发现和开发的大量投资
  • 市场挑战
    • 新开发药品与包装材料和仿冒品广告之间的竞争

波特五力：驾驭药品合约包装市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药品合约包装市场的外部影响

外部宏观环境因素在塑造药品合约包装市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解药品合约包装市场的竞争状况

对药品合约包装市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵药品合约包装市场供应商绩效评估

FPNV定位矩阵是评估药品合约包装市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘药品合约包装市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对药品合约包装市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 製药业对方便且防篡改的包装的需求日益增长。
      • 全球药品生产和出口增加
      • 严格的药品包装政府标准
    • 抑制因素
      • 先进和客製化的药品合约包装服务高成本
    • 机会
      • 药品包装解决方案的技术进步
      • 对药物发现和开发的大量投资
    • 任务
      • 新开发药品违反包装材料及广告仿冒品
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 药品合约包装市场：依材料分类

  • 铝箔
  • 玻璃
  • 纸/纸板
  • 塑胶和聚合物

第七章 药品合约包装市场：依应用分类

  • 安瓿
  • 泡壳包装
  • 瓶子
  • 管瓶

第八章美洲药品合约包装市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太药品合约包装市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲药品合约包装市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Almac Group
  • AmeriPac, Inc.
  • Aphena Pharma Solutions Inc.
  • Assemblies Unlimited Inc.
  • Baxter Pharmaceutical Solutions LLC
  • Catalent, Inc.
  • Central Pharma Contract Packing Limited
  • Daito Pharmaceutical Co., Ltd.
  • Daklapack Group
  • Finishing Services
  • Jam Jams Group
  • Jones Healthcare Group
  • MJS Packaging
  • Nelipak Corporation
  • Nipro Corporation
  • Patheon Pharma Services by Thermo Fisher Scientific Inc.
  • PCI Pharma Services
  • Pfizer Inc.
  • Reed-Lane, Inc.
  • Ropack Inc.
  • Sepha Limited
  • Sharp Services, LLC
  • Southwest Packaging
  • SternMaid GmbH
  • Unicep Packaging, LLC
  • Wasdell Group
  • West Pharmaceutical Services, Inc.
Product Code: MRR-2A0283E25592

The Pharmaceutical Contract Packaging Market was valued at USD 32.07 billion in 2023, expected to reach USD 34.82 billion in 2024, and is projected to grow at a CAGR of 8.91%, to USD 58.30 billion by 2030.

Pharmaceutical contract packaging refers to the outsourcing of packaging services by pharmaceutical companies to third-party providers. This industry segment is essential because it allows pharmaceutical companies to focus on their core competencies, such as drug development and marketing, while leveraging the specialized expertise and capabilities of contract packagers in ensuring compliance with industry standards and regulations. The necessity of contract packaging stems from the increasing complexity of drug formulations and packaging requirements, heightened regulatory scrutiny, and the push towards more sustainable packaging solutions. Applications of contract packaging include blister packaging, bottle filling, labeling, and secondary packaging, with end-use scope spanning from contract manufacturing organizations (CMOs) to pharma companies producing over-the-counter (OTC) medications and prescription drugs.

KEY MARKET STATISTICS
Base Year [2023] USD 32.07 billion
Estimated Year [2024] USD 34.82 billion
Forecast Year [2030] USD 58.30 billion
CAGR (%) 8.91%

Market insights indicate that key growth factors include heightened demand for biologics and specialty drugs necessitating innovative packaging solutions, increased outsourcing trends in the pharma industry, and advancements in packaging technologies like serialization and track-and-trace systems. Opportunities for market players include expanding service portfolios to encompass eco-friendly packaging solutions and adopting digital technologies to streamline packaging processes. Moreover, geographic expansion into emerging markets with growing pharmaceutical industries presents a lucrative prospect. However, challenges include stringent regulatory requirements, cost pressures, and demand fluctuations due to global economic uncertainties.

Innovation prospects lie in developing smart packaging solutions that enhance patient adherence, improve supply chain transparency, and facilitate authentication. Continued research into biodegradable and recyclable materials can offer a competitive edge. The nature of the market is highly competitive and dynamic, driven by rapid technological advancements and regulatory changes. For sustainable business growth, companies should invest in state-of-the-art technologies and foster strategic partnerships or alliances to enhance their service offerings. Additionally, a proactive approach to compliance and a strong focus on customer-specific needs will be critical in navigating the challenges and seizing opportunities in this evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Contract Packaging Market

The Pharmaceutical Contract Packaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing need for convenient and tamper-free packaging in pharmaceutical industries
    • Rise manufacturing and export of pharmaceutical products worldwide
    • Stringent government standards for pharmaceutical packaging
  • Market Restraints
    • High cost of advanced and customized pharmaceutical contract packaging services
  • Market Opportunities
    • Technological advancements in pharmaceutical packaging solutions
    • Significant investments in drug discovery and development
  • Market Challenges
    • Newly developed drugs conflicting with packaging material and advertising forged products

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Contract Packaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Contract Packaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Contract Packaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Contract Packaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Contract Packaging Market

A detailed market share analysis in the Pharmaceutical Contract Packaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Contract Packaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Contract Packaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Contract Packaging Market

A strategic analysis of the Pharmaceutical Contract Packaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Contract Packaging Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Almac Group, AmeriPac, Inc., Aphena Pharma Solutions Inc., Assemblies Unlimited Inc., Baxter Pharmaceutical Solutions LLC, Catalent, Inc., Central Pharma Contract Packing Limited, Daito Pharmaceutical Co., Ltd., Daklapack Group, Finishing Services, Jam Jams Group, Jones Healthcare Group, MJS Packaging, Nelipak Corporation, Nipro Corporation, Patheon Pharma Services by Thermo Fisher Scientific Inc., PCI Pharma Services, Pfizer Inc., Reed-Lane, Inc., Ropack Inc., Sepha Limited, Sharp Services, LLC, Southwest Packaging, SternMaid GmbH, Unicep Packaging, LLC, Wasdell Group, and West Pharmaceutical Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Contract Packaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Material, market is studied across Aluminum Foil, Glass, Paper & Paperboard, and Plastics & Polymers.
  • Based on Application, market is studied across Ampoules, Blister Packs, Bottles, and Vials.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need for convenient and tamper-free packaging in pharmaceutical industries
      • 5.1.1.2. Rise manufacturing and export of pharmaceutical products worldwide
      • 5.1.1.3. Stringent government standards for pharmaceutical packaging
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced and customized pharmaceutical contract packaging services
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in pharmaceutical packaging solutions
      • 5.1.3.2. Significant investments in drug discovery and development
    • 5.1.4. Challenges
      • 5.1.4.1. Newly developed drugs conflicting with packaging material and advertising forged products
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Contract Packaging Market, by Material

  • 6.1. Introduction
  • 6.2. Aluminum Foil
  • 6.3. Glass
  • 6.4. Paper & Paperboard
  • 6.5. Plastics & Polymers

7. Pharmaceutical Contract Packaging Market, by Application

  • 7.1. Introduction
  • 7.2. Ampoules
  • 7.3. Blister Packs
  • 7.4. Bottles
  • 7.5. Vials

8. Americas Pharmaceutical Contract Packaging Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pharmaceutical Contract Packaging Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Contract Packaging Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Almac Group
  • 3. AmeriPac, Inc.
  • 4. Aphena Pharma Solutions Inc.
  • 5. Assemblies Unlimited Inc.
  • 6. Baxter Pharmaceutical Solutions LLC
  • 7. Catalent, Inc.
  • 8. Central Pharma Contract Packing Limited
  • 9. Daito Pharmaceutical Co., Ltd.
  • 10. Daklapack Group
  • 11. Finishing Services
  • 12. Jam Jams Group
  • 13. Jones Healthcare Group
  • 14. MJS Packaging
  • 15. Nelipak Corporation
  • 16. Nipro Corporation
  • 17. Patheon Pharma Services by Thermo Fisher Scientific Inc.
  • 18. PCI Pharma Services
  • 19. Pfizer Inc.
  • 20. Reed-Lane, Inc.
  • 21. Ropack Inc.
  • 22. Sepha Limited
  • 23. Sharp Services, LLC
  • 24. Southwest Packaging
  • 25. SternMaid GmbH
  • 26. Unicep Packaging, LLC
  • 27. Wasdell Group
  • 28. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL CONTRACT PACKAGING MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PHARMACEUTICAL CONTRACT PACKAGING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PHARMACEUTICAL CONTRACT PACKAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL CONTRACT PACKAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL CONTRACT PACKAGING MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ALUMINUM FOIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PAPER & PAPERBOARD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PHARMACEUTICAL CONTRACT PACKAGING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. PHARMACEUTICAL CONTRACT PACKAGING MARKET, FPNV POSITIONING MATRIX, 2023